-
1
-
-
84873275502
-
De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring–Opitz syndrome
-
Bainbridge MN, Hu H, Muzny DM, Musante L, Lupski JR, Graham BH, Chen W, Gripp KW, Jenny K, Wienker TF, Yang Y, Sutton VR, Gibbs RA, Ropers HH. 2013. De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring–Opitz syndrome. Genome Med 5:11.
-
(2013)
Genome Med
, vol.5
, pp. 11
-
-
Bainbridge, M.N.1
Hu, H.2
Muzny, D.M.3
Musante, L.4
Lupski, J.R.5
Graham, B.H.6
Chen, W.7
Gripp, K.W.8
Jenny, K.9
Wienker, T.F.10
Yang, Y.11
Sutton, V.R.12
Gibbs, R.A.13
Ropers, H.H.14
-
2
-
-
0028895417
-
Exon recognition in vertebrate splicing
-
Berget SM. 1995. Exon recognition in vertebrate splicing. J Biol Chem 270:2411–2414.
-
(1995)
J Biol Chem
, vol.270
, pp. 2411-2414
-
-
Berget, S.M.1
-
3
-
-
84883897762
-
De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies
-
Dinwiddie DL, Soden SE, Saunders CJ, Miller NA, Farrow EG, Smith LD, Kingsmore SF. 2013. De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies. BMC Med Genomics 6:32.
-
(2013)
BMC Med Genomics
, vol.6
, pp. 32
-
-
Dinwiddie, D.L.1
Soden, S.E.2
Saunders, C.J.3
Miller, N.A.4
Farrow, E.G.5
Smith, L.D.6
Kingsmore, S.F.7
-
4
-
-
79955786296
-
Bohring–Opitz (Oberklaid– Danks) syndrome Clinical study, review of the literaturediscussion of possible pathogenesis.
-
Hastings R, Cobben JM, Gillessen-Kaesbach G, Goodship J, Hove H, Kjaergaard S, Kemp H, Kingston H, Lunt P, Mansour S, McGowan R, Metcalfe K, Murdoch-Davis C, Ray M, Rio M, Smithson S, Tolmie J, Turnpenny P, van Bon B, Wieczorek D, Newbury-Ecob R. 2011. Bohring–Opitz (Oberklaid–Danks) syndrome: Clinical study, review of the literature, and discussion of possible pathogenesis. Eur J Hum Genet 19:513–519.
-
(2011)
Eur J Hum Genet
, vol.19
, pp. 513-519
-
-
Hastings, R.1
Cobben, J.M.2
Gillessen-Kaesbach, G.3
Goodship, J.4
Hove, H.5
Kjaergaard, S.6
Kemp, H.7
Kingston, H.8
Lunt, P.9
Mansour, S.10
McGowan, R.11
Metcalfe, K.12
Murdoch-Davis, C.13
Ray, M.14
Rio, M.15
Smithson, S.16
Tolmie, J.17
Turnpenny, P.18
van Bon, B.19
Wieczorek, D.20
Newbury-Ecob, R.21
more..
-
5
-
-
79960909421
-
De novo nonsense mutations in ASXL1 cause Bohring–Opitz syndrome
-
Hoischen A, van Bon BW, Rodriguez-Santiago B, Gilissen C, Vissers LE, de Vries P, Janssen I, van Lier B, Hastings R, Smithson SF, Newbury-Ecob R, Kjaergaard S, Goodship J, McGowan R, Bartholdi D, Rauch A, Peippo M, Cobben JM, Wieczorek D, Gillessen-Kaesbach G, Veltman JA, Brunner HG, de Vries BB. 2011. De novo nonsense mutations in ASXL1 cause Bohring–Opitz syndrome. Nat Genet 43:729–731.
-
(2011)
Nat Genet
, vol.43
, pp. 729-731
-
-
Hoischen, A.1
van Bon, B.W.2
Rodriguez-Santiago, B.3
Gilissen, C.4
Vissers, L.E.5
de Vries, P.6
Janssen, I.7
van Lier, B.8
Hastings, R.9
Smithson, S.F.10
Newbury-Ecob, R.11
Kjaergaard, S.12
Goodship, J.13
McGowan, R.14
Bartholdi, D.15
Rauch, A.16
Peippo, M.17
Cobben, J.M.18
Wieczorek, D.19
Gillessen-Kaesbach, G.20
Veltman, J.A.21
Brunner, H.G.22
de Vries, B.B.23
more..
-
6
-
-
84881108886
-
Functional and cancer genomics of ASXL family members
-
Katoh M. 2013. Functional and cancer genomics of ASXL family members. Br J Cancer 109:299–306.
-
(2013)
Br J Cancer
, vol.109
, pp. 299-306
-
-
Katoh, M.1
-
7
-
-
84859005398
-
Two novel patients with Bohring–Opitz syndrome caused by de novo ASXL1 mutations
-
Magini P, Della Monica M, Uzielli ML, Mongelli P, Scarselli G, Gambineri E, Scarano G, Seri M. 2012. Two novel patients with Bohring–Opitz syndrome caused by de novo ASXL1 mutations. Am J Med Genet Part A 158A:917–921.
-
(2012)
Am J Med Genet Part A
, vol.158A
, pp. 917-921
-
-
Magini, P.1
Della Monica, M.2
Uzielli, M.L.3
Mongelli, P.4
Scarselli, G.5
Gambineri, E.6
Scarano, G.7
Seri, M.8
-
8
-
-
84939467262
-
Clinical management of patients with ASXL1 mutations and Bohring–Opitz syndrome, emphasizing the need for Wilms tumor surveillance
-
Russell B, Johnston JJ, Biesecker LG, Kramer N, Pickart A, Rhead W, Tan WH, Brownstein CA, Kate Clarkson L, Dobson A, Rosenberg AZ, Vergano SA, Helm BM, Harrison RE, Graham JM, Jr. 2015. Clinical management of patients with ASXL1 mutations and Bohring–Opitz syndrome, emphasizing the need for Wilms tumor surveillance. Am J Med Genet Part A 167:2122–2131.
-
(2015)
Am J Med Genet Part A
, vol.167
, pp. 2122-2131
-
-
Russell, B.1
Johnston, J.J.2
Biesecker, L.G.3
Kramer, N.4
Pickart, A.5
Rhead, W.6
Tan, W.H.7
Brownstein, C.A.8
Kate Clarkson, L.9
Dobson, A.10
Rosenberg, A.Z.11
Vergano, S.A.12
Helm, B.M.13
Harrison, R.E.14
Graham, J.M.15
-
9
-
-
84924403099
-
Whole-exome sequencing in undiagnosed genetic diseases: Interpreting 119 trios
-
Zhu X, Petrovski S, Xie P, Ruzzo EK, Lu YF, McSweeney KM, Ben-Zeev B, Nissenkorn A, Anikster Y, Oz-Levi D, Dhindsa RS. 2015. Whole-exome sequencing in undiagnosed genetic diseases: Interpreting 119 trios. Genet Med 17:774–781.
-
(2015)
Genet Med
, vol.17
, pp. 774-781
-
-
Zhu, X.1
Petrovski, S.2
Xie, P.3
Ruzzo, E.K.4
Lu, Y.F.5
McSweeney, K.M.6
Ben-Zeev, B.7
Nissenkorn, A.8
Anikster, Y.9
Oz-Levi, D.10
Dhindsa, R.S.11
|